Comparison between Curis Lifesciences IPO and IMS Mercantiles IPO.
Curis Lifesciences IPO is a SME Bookbuilding IPO proposed to list at NSE SME while IMS Mercantiles IPO is a SME Bookbuilding proposed to list at NSE SME.
| Curis Lifesciences IPO | IMS Mercantiles IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Share India Capital Services Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | MAS Services Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Curis Lifesciences IPO is up to ₹0.00 Cr whereas the issue size of the IMS Mercantiles IPO is up to ₹0.00 Cr. The final issue price of Curis Lifesciences IPO is and of IMS Mercantiles IPO is .
| Curis Lifesciences IPO | IMS Mercantiles IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 22,50,000 shares | 38,78,400 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 12,93,600 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 22,50,000 shares | 51,72,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Curis Lifesciences IPO opens on , while IMS Mercantiles IPO opens on . The closing date of Curis Lifesciences IPO and IMS Mercantiles IPO is , and , respectively.
| Curis Lifesciences IPO | IMS Mercantiles IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Curis Lifesciences IPO P/E ratio is , as compared to IMS Mercantiles IPO P/E ratio of .
| Curis Lifesciences IPO | IMS Mercantiles IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Curis Lifesciences Limited Financial Information (Restated)
| Ims Mercantiles Limited Financial Information (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.68 | 97.75 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 145.20% | 37.02% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 34.89% | 30.83% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.86 | 0.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 84.12% | 37.02% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Curis Lifesciences IPO Retail Individual Investors (RII) are offered 0 shares while in IMS Mercantiles IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Curis Lifesciences IPO and in IMS Mercantiles IPO.
| Curis Lifesciences IPO | IMS Mercantiles IPO | |
|---|---|---|
| Anchor Investor Reserveration | 0 shares | |
| Market Maker Reserveration | 0 shares | 2,59,200 shares |
| QIB | 0 shares | |
| NII | 0 shares | |
| RII | 0 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares |
Curis Lifesciences IPO subscribed in total, whereas IMS Mercantiles IPO subscribed .
| Curis Lifesciences IPO | IMS Mercantiles IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
